Revolade (Eltrombopag)
eltrombopag 50 mg tablet, 28 · ORAL · PBS code 14121F
AUTHORITY_REQUIREDWhat it costs
AU$2456.24 PBS-determined price per 84 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2024-05-01.
- • Repeats: 3.
- • PBS program: HB.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Severe aplastic anaemia
Initial treatment - Second line treatment
The condition must be severe aplastic anaemia; AND
Patient must not have achieved an adequate response to prior immunosuppressive therapy including anti-thymocyte antibody and ciclosporin; or
Patient must have relapsed following prior immunosuppressive therapy including anti-thymocyte antibody and ciclosporin; AND
Patient must not receive more than 16 weeks of treatment under this restriction.
The authority application must be made via the online PBS Authorities (real time assessment), or in writing via HPOS form upload or mail and must include:
(a) prior immunosuppressive therapy, including dates of treatment.
If the application is submitted through HPOS form upload or mail, it must include:
(i) details of the proposed prescription; and
(ii) a completed authority application form relevant to the indication and treatment phase (the latest version is located on the website specified in the Administrative Advice).
Sponsor: Novartis Pharmaceuticals Australia Pty Limited ABN 18 004 244 160
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.